Curiox Biosystems Q3 operating loss widens to ₩4B
Predicted impact: Medium
Q3 operating loss of ₩4B is large against ₩5.7B revenue, but preliminary results were already filed.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.